Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (51-60 of 325) with videos related to

Pageof 33
Sort By:
Leukemia|September 13, 2022
Is unmeasurable residual disease (uMRD) the best surrogate endpoint for clinical trials, regulatory approvals and therapy decisions in chronic lymphocytic leukaemia (CLL)?Shenmiao Yang, Neil E Kay, Min Shi, et al.
Blood Reviews|February 13, 2022
CLL update 2022: A continuing evolution in careNeil E Kay, Paul J Hampel, Daniel L Van Dyke, et al.
Leukemia & Lymphoma|April 6, 2004
Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488Martin M Oken, Sandra Lee, Neil E Kay, et al.
Leukemia & Lymphoma|April 18, 2009
N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemiaNeil E Kay, Tait D Shanafelt, Timothy G Call, et al.
Blood|November 1, 2017
Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysisStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Leukemia Research|September 26, 2013
Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012Megan Ratterman, Kimberly Kruczek, Suela Sulo, et al.
Leukemia & Lymphoma|October 27, 2006
Update on risk-stratified management for chronic lymphocytic leukemiaClive S Zent, Timothy G Call, William J Hogan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2005
Protein expression profiling of CLL B cells using replicate off-line strong cation exchange chromatography and LC-MS/MSDavid R Barnidge, Renee C Tschumper, Diane F Jelinek, et al.
Annals of Internal Medicine|September 20, 2006
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemiaTait D Shanafelt, John C Byrd, Timothy G Call, et al.
Leukemia|September 28, 2021
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?Shenmiao Yang, Neil E Kay, Min Shi, et al.
Pageof 33

Showing results (51-60 of 325) with videos related to

Sort By:
Pageof 33
Leukemia|September 13, 2022
Is unmeasurable residual disease (uMRD) the best surrogate endpoint for clinical trials, regulatory approvals and therapy decisions in chronic lymphocytic leukaemia (CLL)?Shenmiao Yang, Neil E Kay, Min Shi, et al.
Blood Reviews|February 13, 2022
CLL update 2022: A continuing evolution in careNeil E Kay, Paul J Hampel, Daniel L Van Dyke, et al.
Leukemia & Lymphoma|April 6, 2004
Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488Martin M Oken, Sandra Lee, Neil E Kay, et al.
Leukemia & Lymphoma|April 18, 2009
N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemiaNeil E Kay, Tait D Shanafelt, Timothy G Call, et al.
Blood|November 1, 2017
Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysisStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Leukemia Research|September 26, 2013
Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012Megan Ratterman, Kimberly Kruczek, Suela Sulo, et al.
Leukemia & Lymphoma|October 27, 2006
Update on risk-stratified management for chronic lymphocytic leukemiaClive S Zent, Timothy G Call, William J Hogan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2005
Protein expression profiling of CLL B cells using replicate off-line strong cation exchange chromatography and LC-MS/MSDavid R Barnidge, Renee C Tschumper, Diane F Jelinek, et al.
Annals of Internal Medicine|September 20, 2006
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemiaTait D Shanafelt, John C Byrd, Timothy G Call, et al.
Leukemia|September 28, 2021
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?Shenmiao Yang, Neil E Kay, Min Shi, et al.
Pageof 33